IS4702A - Nýjar [(3-alkoxý-fenoxý)-etýl]-díalkýlamínafleiður, lyfjablanda, notkun á afleiðunum til að búa tilstaðbundin deyfingarlyf og aðferð til að framleiða þau - Google Patents

Nýjar [(3-alkoxý-fenoxý)-etýl]-díalkýlamínafleiður, lyfjablanda, notkun á afleiðunum til að búa tilstaðbundin deyfingarlyf og aðferð til að framleiða þau

Info

Publication number
IS4702A
IS4702A IS4702A IS4702A IS4702A IS 4702 A IS4702 A IS 4702A IS 4702 A IS4702 A IS 4702A IS 4702 A IS4702 A IS 4702A IS 4702 A IS4702 A IS 4702A
Authority
IS
Iceland
Prior art keywords
derivatives
phenoxy
alkoxy
ethyl
producing
Prior art date
Application number
IS4702A
Other languages
English (en)
Other versions
IS1932B (is
Inventor
Sandberg Rune
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9503798A external-priority patent/SE9503798D0/xx
Priority claimed from SE9600329A external-priority patent/SE9600329D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS4702A publication Critical patent/IS4702A/is
Publication of IS1932B publication Critical patent/IS1932B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IS4702A 1995-10-27 1998-03-25 Nýjar [(3-alkoxý-fenoxý)-etýl]-díalkýlamínafleiður, lyfjablanda, notkun á afleiðunum til að búa tilstaðbundin deyfingarlyf og aðferð til að framleiða þau IS1932B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9503798A SE9503798D0 (sv) 1995-10-27 1995-10-27 New anaesthetic componds
SE9600329A SE9600329D0 (sv) 1996-01-30 1996-01-30 New anaesthetic compounds
PCT/SE1996/001361 WO1997015548A1 (en) 1995-10-27 1996-10-23 New [(3-alkoxy-phenoxy)-ethyl]-dialkylamine derivatives and their use as local anaesthetics

Publications (2)

Publication Number Publication Date
IS4702A true IS4702A (is) 1998-03-25
IS1932B IS1932B (is) 2004-06-16

Family

ID=26662410

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4702A IS1932B (is) 1995-10-27 1998-03-25 Nýjar [(3-alkoxý-fenoxý)-etýl]-díalkýlamínafleiður, lyfjablanda, notkun á afleiðunum til að búa tilstaðbundin deyfingarlyf og aðferð til að framleiða þau

Country Status (30)

Country Link
US (1) US6310252B1 (is)
EP (1) EP0858445B1 (is)
JP (1) JP4101877B2 (is)
KR (1) KR100460652B1 (is)
CN (1) CN1113856C (is)
AR (1) AR004691A1 (is)
AT (1) ATE215061T1 (is)
AU (1) AU704635B2 (is)
BR (1) BR9611234A (is)
CA (1) CA2233489C (is)
CZ (1) CZ124198A3 (is)
DE (1) DE69620213T2 (is)
DK (1) DK0858445T3 (is)
EE (1) EE03963B1 (is)
ES (1) ES2174113T3 (is)
HK (1) HK1009437A1 (is)
HU (1) HUP9901212A3 (is)
IL (1) IL123916A (is)
IS (1) IS1932B (is)
MY (1) MY132329A (is)
NO (1) NO310614B1 (is)
NZ (1) NZ320757A (is)
PL (1) PL186783B1 (is)
PT (1) PT858445E (is)
SI (1) SI0858445T1 (is)
SK (1) SK282757B6 (is)
TR (1) TR199800714T2 (is)
TW (1) TW448142B (is)
UA (1) UA59347C2 (is)
WO (1) WO1997015548A1 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
SE9704031D0 (sv) * 1997-11-05 1997-11-05 Astra Ab Novel formulation
SE9704770D0 (sv) * 1997-12-19 1997-12-19 Astra Ab New use
SE9704834D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New process
SE9704835D0 (sv) 1997-12-22 1997-12-22 Astra Ab New compound
JP2000302737A (ja) * 1999-04-16 2000-10-31 Shiseido Co Ltd 二置換ベンゼン誘導体
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9012477B2 (en) 2009-01-06 2015-04-21 Nuvo Research Inc. Method of treating neuropathic pain
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
AU2011205730C1 (en) 2010-01-14 2014-10-09 Nuvo Research Inc. Solid-forming local anesthetic formulations for pain control

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1173136A (fr) 1955-11-16 1959-02-20 Rech S Et Tech Appliquees Dérivés tertio-amino-alcoxylés du benzène et leur procédé de préparation
CH380746A (de) * 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
GB1027611A (en) * 1962-01-04 1966-04-27 May & Baker Ltd Phenoxy- and phenylthio-alkylamines and acid addition salts thereof
US3205136A (en) 1962-12-24 1965-09-07 Smith Kline French Lab Antidepressant phenyloxyalkylamines
DE3233828A1 (de) 1982-09-11 1984-03-15 Basf Ag, 6700 Ludwigshafen Aryloxyalkylamine, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses

Also Published As

Publication number Publication date
DE69620213D1 (de) 2002-05-02
EE9800088A (et) 1998-10-15
DE69620213T2 (de) 2002-10-17
HUP9901212A2 (hu) 1999-10-28
CA2233489A1 (en) 1997-05-01
EE03963B1 (et) 2003-02-17
US6310252B1 (en) 2001-10-30
EP0858445A1 (en) 1998-08-19
TR199800714T2 (xx) 1998-07-21
CA2233489C (en) 2005-02-22
JPH11513708A (ja) 1999-11-24
NO981825D0 (no) 1998-04-23
IS1932B (is) 2004-06-16
DK0858445T3 (da) 2002-07-01
NO981825L (no) 1998-04-23
CN1200723A (zh) 1998-12-02
NO310614B1 (no) 2001-07-30
EP0858445B1 (en) 2002-03-27
UA59347C2 (uk) 2003-09-15
CZ124198A3 (cs) 1998-09-16
WO1997015548A1 (en) 1997-05-01
KR19990067083A (ko) 1999-08-16
ATE215061T1 (de) 2002-04-15
SK55398A3 (en) 1999-02-11
NZ320757A (en) 1999-08-30
BR9611234A (pt) 1999-07-13
KR100460652B1 (ko) 2005-04-14
PT858445E (pt) 2002-09-30
HUP9901212A3 (en) 2000-02-28
JP4101877B2 (ja) 2008-06-18
HK1009437A1 (en) 1999-06-04
ES2174113T3 (es) 2002-11-01
AR004691A1 (es) 1999-03-10
CN1113856C (zh) 2003-07-09
MY132329A (en) 2007-10-31
SI0858445T1 (en) 2002-08-31
AU7356196A (en) 1997-05-15
TW448142B (en) 2001-08-01
SK282757B6 (sk) 2002-12-03
IL123916A (en) 2001-10-31
PL186783B1 (pl) 2004-02-27
PL326425A1 (en) 1998-09-14
AU704635B2 (en) 1999-04-29

Similar Documents

Publication Publication Date Title
HUP0001322A3 (en) Sulphinic acid derivatives, method for producing them, and their use
FI964395A (fi) Uudet erytromysiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
HUP0105478A3 (en) 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
HU9802422D0 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and their medical use
DK0739898T3 (da) Phosphononmoneosternukleinsyrer, fremgangsmåde til fremstilling deraf og anvendelse deraf
HUP9802300A3 (en) N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use
NO973612D0 (no) Nytt farmasöytisk preparat
EE9700232A (et) Olansapiini polümorfne vorm II, selle saamismeetod ja farmatseutiline preparaat
FI955913A (fi) Uudet erytromysiinijohdannaiset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
EE9800065A (et) 5-O-desosaminüül-6-O-metüülerütronoliid A uued derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
PL312270A1 (en) Novel derivatives of indolopiperidine, method of obtaining them and pharmaceutical preparation and method of obtaining same
IS4635A (is) 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
IS4702A (is) Nýjar [(3-alkoxý-fenoxý)-etýl]-díalkýlamínafleiður, lyfjablanda, notkun á afleiðunum til að búa tilstaðbundin deyfingarlyf og aðferð til að framleiða þau
HUP9600876A3 (en) Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP0002300A3 (en) Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use
NO961000D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
GB2304714B (en) New piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
EE9800109A (et) 5-O-desosaminüül-6-O-metüülerütronoliid A uued derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
HUP0103316A3 (en) 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use
NO304949B1 (no) Nye glukose- og soforoselipider, en fremgangsmÕte for fremstilling derav og anvendelse av lipidene
AU7257891A (en) New benzimidazole derivatives, method for preparing them and their pharmaceutical use
NO973610D0 (no) Nytt farmasöytisk preparat
HUP0001827A3 (en) Colchicine derivatives, process for producing them, pharmaceutical compositions containing them, and use thereof for producing pharmaceutical compositions
IS1826B (is) Aðferð til að framleiða felódipín og aðferð til að framleiða lyfjablöndu